Ardelyx Inc

NASDAQ:ARDX   3:59:40 PM EDT
6.61
-0.10 (-1.56%)
Products

Ardelyx Announces FDA Acceptance For Filing Of NDA Of Tenapanor

Published: 09/15/2020 12:51 GMT
Ardelyx Inc (ARDX) - Ardelyx Announces FDA Acceptance for Filing of Its New Drug Application of Tenapanor for the Control of Serum Phosphorus in Adult Patients With Ckd on Dialysis.
Ardelyx Inc - FDA Has Set a Prescription Drug User Fee Act Goal Date of April 29, 2021 for Tenapanor.